+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Distribution by Type of Product, Type of Organ, Type of Single Organ based Model, Type of Material of Construction, Purpose, Application Area, End User, Key Geographical Regions and Leading Players- Product Image
Distribution by Type of Product, Type of Organ, Type of Single Organ based Model, Type of Material of Construction, Purpose, Application Area, End User, Key Geographical Regions and Leading Players- Product Image
New

Distribution by Type of Product, Type of Organ, Type of Single Organ based Model, Type of Material of Construction, Purpose, Application Area, End User, Key Geographical Regions and Leading Players

  • PDF Icon

    Report

  • 199 Pages
  • December 2025
  • Region: Global
  • Roots Analysis
  • ID: 6215981
Description Jump to:
The global DNA synthesis market is estimated to grow from USD 1.2 billion in the current year to USD 8.6 billion by 2035, at a CAGR of 22% during the forecast period, till 2035.

DNA SYNTHESIS MARKET: GROWTH AND TRENDS

The process of DNA synthesis involves creating deoxyribonucleic acid (DNA) molecules that are utilized in producing gene therapies and other therapeutic areas. The increasing trend of tailored treatments to address specific patient needs has heightened the demand for DNA or RNA molecules for numerous therapeutic purposes. DNA molecules are also essential in medical research, disease detection, analytical procedures, and forensic analysis. Numerous studies have taken place to assess the therapeutic application of oligonucleotides, especially DNA, for different medical issues. Moreover, the oligonucleotide molecules are now utilized in diagnosing genetic diseases, including cancer, ovarian cancer, dyslexia, psoriasis, and Parkinson's disease.

Advanced technologies such as genetic modification, genome sequencing, gel electrophoresis, and recombinant DNA methods enable researchers to design precise oligonucleotides for medical progress. Numerous DNA-based treatments have been developed by pharmaceutical firms to aid in the management of different illnesses, thus contributing significantly towards the market.

It is important to highlight that numerous DNA synthesis companies are offering technologies and services to enhance the production of DNA molecules. Significantly, companies operating in this domain have developed unique enzymatic DNA synthesis systems that offer improved accessibility and convenience over DNA replication methods, in addition to extending the length of DNA strands. Due to the precision and management offered by high-throughput technologies, numerous researchers and developers of oligonucleotide-based therapies opt to outsource DNA replication and synthesis processes to external service providers with the required expertise.

Driven by the increasing demand for naturally or synthetically generated DNA, several industry leaders have shown a strong interest in this field to improve the efficiency, and precision of the DNA manufacturing process.

DNA SYNTHESIS MARKET: KEY INSIGHTS

The report delves into the current state of the DNA synthesis market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Around 65 companies presently claim to have the required expertise for DNA synthesis technologies and affiliated services; of these, more than 50% of players are small companies and have recently been established.
  • There has been a notable increase in the published scientific literature related to DNA synthesis technologies and services in the last few years; such articles have been published in over 50 countries.
  • The growing interest in DNA synthesis technologies and services is reflected by the increase in partnership activity in the recent past; in fact, between 2019 and 2021, the partnership activity increased at a CAGR of 18%.
  • Over the past few years, 150 academic grants have been awarded to various organizations in order to support the ongoing efforts related to research and innovation in the field of DNA synthesis technologies.
  • Several investors, having realized the future opportunity associated with DNA synthesis technologies and services market, have invested more than USD 750 million in the past five years.

  • More than 11,000 patents have been filed / granted related to DNA synthesis technologies Since 2016, establishing a strong portfolio of intellectual property within this industry.

  • The DNA synthesis services market is expected to witness an annualized growth rate of more than 22% till 2035; the opportunity is likely to be distributed across methods of synthesis applications, company sizes and geographies.

DNA SYNTHESIS MARKET: KEY SEGMENTS

Chemical Method Accounts for the Highest Share of DNA Synthesis Market

In terms of method of DNA synthesis, the market is segmented into chemical and enzymatic methods. Our estimates suggest that the chemical method accounts for the largest share of the market in the current year and is poised to hold 57% of the overall revenue share by 2035. Owing to the growing usage of enzymes for DNA isolation and synthesis, the enzymatic method is likely to grow at a higher CAGR of 21% during the forecast period.

Research and Diagnostics Capture Most of the Market Share in the Current Year

In terms of key application areas, the global DNA synthesis market is distributed across research & diagnostics and therapeutic applications. It is worth noting that research & diagnostic applications are likely to hold 61% of the overall revenue share by 2035. Further, therapeutic applications are likely to grow at a higher CAGR during the forecast period, owing to the rising interest in nucleic acid-based therapies, gene therapy, and personalized treatment.

Presently, Large Companies Occupy the Majority of the DNA Synthesis Market Share

In terms of company size, the DNA synthesis market has been distributed among small, mid-sized, and large companies. In the current year, large companies are estimated to hold majority of the overall revenue share. Further, small companies are expected to grow at a CAGR of 20.9% during the forecast period.

Asia-Pacific is Likely to Grow at a Higher CAGR During the Forecast Period

In terms of geographical regions, the DNA synthesis market is segmented across North America, Europe, Asia-Pacific, and the rest of the world. North America currently accounts for the largest share of the market and is expected to hold 50% of the overall share of the market by 2035. In Asia-Pacific and the rest of the world, the market will grow at a higher CAGR of 21% during the forecast period.

Example Players in the DNA Synthesis Market

  • Ajinomoto Bio-Pharma Services
  • ATUM
  • DNA Script
  • Eurofins Genomics
  • Gene Universal
  • GenScript
  • Synbio Technologies

DNA SYNTHESIS MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features a thorough analysis of the global DNA synthesis market, in terms of the key market segments, including [A] method of DNA synthesis, [B] key application areas, [C] company size, [D] therapeutic area, [E] key geographical regions.
  • Market Landscape: An in-depth assessment of the companies involved in DNA synthesis market, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of offering, [E] method of DNA synthesis [F] type of DNA molecule, [G] custom offerings, and [H] application area.
  • Company Profiles: Detailed profiles of key service providers across North America, Europe and Asia-Pacific engaged in the DNA synthesis market, focused on parameters such as [A] company overview, [B] financial information (if available), [C] service portfolio, [D] manufacturing facilities and [E] recent developments and an informed future outlook.
  • Case Study 1: A case study providing a detailed overview of the current market landscape of oligonucleotide manufacturers focused on research and diagnostic applications, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] scale of operation, [D] location of headquarters, [E] number of manufacturing facilities, [F] location of facility, [G] regulatory accreditations and certifications received, [H] type of oligonucleotide manufactured, [I] type of offering, [J] type of manufacturing service(s) offered and [K] type of modification(s) offered.
  • Case Study 2: A case study featuring a detailed overview of the current market landscape of oligonucleotide manufacturers focused on therapeutic applications, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] scale of operation, [D]location of headquarters, [E] number of manufacturing facilities, along with information [F] location of facility, [G] regulatory accreditations and certifications received, [H] type of oligonucleotide manufactured, [I] type of offering, [J] type of manufacturing service(s) offered.
  • Partnerships and Collaborations: An in-depth analysis of the partnership’s activity reported in this domain, based on parameters such as [A] year of partnership, [B] type of partnership [C] scale of operation, and [D] type of partner company.
  • Funding and Investment Analysis: A detailed analysis of funding and investments made in the domain, including [A] seed financing, [B] venture capital financing, [C] debt financing, [D] grants, [E] capital raised from IPOs and [F] subsequent offerings, at various stages of development.
  • Grant Analysis: An in-depth analysis of grants that have been awarded to various research institutes for projects related to DNA synthesis technologies and services, Since 2017, on the basis of important parameters, such as [A] year of grant award, [B] grant amount awarded, [C] administering institute center, [D] support period, [E] type of grant application, [F] grant activity code, [G] emerging focus area, [H] purpose of grant award, [I] type of recent organization, popular NIH department and [J] prominent program officers.
  • Publication Analysis: A detailed review of more than 12,000 peer-reviewed, scientific articles related to research on DNA synthesis technologies, which have been published Since 2017, including analysis based on parameters, such as [D] year of publication, [D] key focus area, [D] type of article, [D] popular keywords, [D] popular authors, [D] therapeutic area, geography and key journals (in terms of number of articles published in this domain and impact factor of the journal).
  • Patent Analysis: An overview of the various patents that have been filed / granted, based on various parameters, such as publication year, geography, [D] CPC symbols, emerging focus areas, [D] type of applicant and [D] leading industry players.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with the Research Team
  • Free Update if the Report is 6+ Months Old

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to DNA Synthesis
3.3. Components of DNA Synthesis
3.3.1. Substrates
3.3.2. Template
3.3.3. Primer
3.3.4. Enzymes
3.3.5. Leading Strand Synthesis
3.3.6. Lagging Strand Synthesis
3.4. DNA Synthesis Technologies
3.4.1. Chemical Method of DNA Synthesis
3.4.2. Enzymatic Method of DNA Synthesis
3.5. Applications of DNA Synthesis
3.6. Future Perspectives
4. MARKET OVERVIEW: DNA SYNTHESIS TECHNOLOGIES AND SERVICES
4.1. Chapter Overview
4.2. DNA Synthesis Technologies and Services: Overall Market Landscape
4.2.1. Analysis by Type of Offering
4.2.2. Analysis by Method of DNA Synthesis
4.2.3. Analysis by Type of DNA Molecule
4.2.4. Analysis by Custom Offerings
4.2.5. Analysis by Application Area
4.3. DNA Synthesis Technologies and Services: Key Industry Players
4.3.1 Analysis by Year of Establishment
4.3.2 Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Application Area and Region
5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Ajinomoto Bio-Pharma Services
5.2.1. Company Overview
5.2.2. Financial Information
5.2.3. Technology / Service Portfolio
5.2.4. Recent Developments and Future Outlook
5.3. ATUM
5.3.1. Company overview
5.3.2. Technology / Service Portfolio
5.3.3. Recent Developments and Future Outlook
5.4. DNA Script
5.4.1. Company Overview
5.4.2. Technology / Service Portfolio
5.4.3. Recent Developments and Future Outlook
5.5. Eurofins Genomics
5.5.1. Company Overview
5.5.2. Financial Information
5.5.3. Technology / Service Portfolio
5.5.4. Recent Developments and Future Outlook
5.6. Gene Universal
5.6.1. Company Overview
5.6.2. Technology / Service Portfolio
5.6.3. Recent Developments and Future Outlook
5.7. GenScript
5.7.1. Company Overview
5.7.2. Financial Information
5.7.3. Technology / Service Portfolio
5.7.4. Recent Developments and Future Outlook
5.8. Synbio Technologies
5.8.1. Company overview
5.8.2. Technology / Service Portfolio
5.8.3. Recent Developments and Future Outlook
6. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (RESEARCH AND DIAGNOSTIC APPLICATIONS)
6.1. Chapter Overview
6.2. Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Scale of Operation
6.2.4. Analysis by Geographical Location
6.2.5. Analysis by Location of Manufacturing Facilities
6.2.6. Analysis by Regulatory Accreditations / Certifications Received
6.2.7. Analysis by Type of Oligonucleotide Manufactured
6.2.8. Analysis by Type of Offering
6.2.9. Analysis by Type of Manufacturing Service Offered
6.2.10. Analysis by Type of Modification
7. CASE STUDY: OLIGONUCLEOTIDE MANUFACTURERES (THERAPEUTIC APPLICATIONS)
7.1. Chapter Overview
7.2. Oligonucleotide Manufacturers Focused on Therapeutic Applications: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Scale of Operation
7.2.4. Analysis by Geographical Location
7.2.5. Analysis by Location of Manufacturing Facilities
7.2.6. Analysis by Regulatory Accreditations / Certifications
7.2.7. Analysis by Type of Oligonucleotide Manufactured
7.2.8. Analysis by Type of Offering
7.2.9. Analysis by Type of Manufacturing Service Offered
7.2.10. Analysis by Type of Modification
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. DNA Synthesis Technologies and Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Type of Partner
8.3.4. Analysis by Year and Type of Partner
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Regional Analysis
8.3.6.1. Intercontinental and Intracontinental Agreements
9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. DNA Synthesis Technologies: Recent Funding Instances
9.4. Analysis by Year of Investment
9.5. Analysis by Amount Invested
9.5. Analysis by Amount Invested
9.6. Analysis by Type of Funding and Amount Invested
9.7. Analysis by Venture Capital Funding
9.8. Most Active Players: Analysis by Number of Funding Instances
9.9. Key Investors: Analysis by Number of Funding Instances
9.10. Regional Analysis by Amount Invested
9.11. Funding and Investment Summary
10. GRANT ANALYSIS
10.1 Chapter Overview
10.2. Analysis Methodology and Key Parameters
10.3. DNA Synthesis Technologies and Services: List of Academic Grants
10.3.1. Analysis by Year of Grant Award
10.3.2. Analysis by Grant Amount Awarded
10.3.3. Analysis by Administering Institute Center
10.3.4. Analysis by Support Period
10.3.5. Analysis by Administering Institute Center and Support Period
10.3.6. Analysis by Type of Grant Application
10.3.7. Analysis by Grant Activity Code
10.3.8. Word Cloud of Study Titles
10.3.9. Analysis by Purpose of Grant Award
10.3.10. Popular NIH Departments: Analysis by Number of Grants
10.3.11. Analysis by Type of Recipient Organization
10..12. Prominent Program Officers: Analysis by Number of Grants
11. PUBLICATION ANALYSIS
11.1. Chapter Overview
11.2. Analysis Methodology and Key Parameters
11.3. Analysis by Year of Publication
11.4. Analysis by Quarterly Distribution of Publication
11.5. Analysis by Type of Article
11.6. Analysis by Popular Keywords
11.7. Most Popular Authors: Analysis by Number of Publications
11.8. Popular Publishers: Analysis by Number of Publications
11.9. Popular Journals: Analysis by Number of Publications
11.10. Analysis by Therapeutic Area
11.11. Geographical Analysis
12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Analysis Methodology and Key Parameters
12.3. DNA Synthesis Technologies and Services: Patent Analysis
12.3.1. Analysis by Type of Patent
12.3.2. Analysis by Publication Year
12.3.3. Analysis by Type of Patent and Publication Year
12.3.4. Analysis by Issuing Authority
12.3.5. Analysis by CPC Symbols
12.3.6. Analysis by Type of Applicant
12.3.7. Word Cloud Analysis: Emerging Focus Areas
12.3.8. Leading Industry Players: Analysis by Number of Patents
12.3.9. Leading Non-Industry Players: Analysis by Number of Patents
12.3.10. Leading Players: Analysis by Number of Patents
12.3.11. Leading Patents: International Patents
12.3.12. Analysis by Patent Characteristics
12.3.13. Patent Valuation Analysis
13. DNA SYNTHESIS SERVICES: MARKET FORECAST AND OPPORTUNITY ANALYSIS
13.1 Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Global DNA Synthesis Services Market
13.3.1. Global DNA Synthesis Services Market: Distribution by Method of DNA Synthesis
13.3.2. Global DNA Synthesis Services Market: Distribution by Application Area
13.3.3. Global DNA Synthesis Services Market: Distribution by Company Size
13.3.4. Global DNA Synthesis Services Market: Distribution by Geography
13.4. DNA Synthesis Services Market in North America
13.4.1. DNA Synthesis Services Market in North America: Distribution by Method of DNA Synthesis
13.4.2. DNA Synthesis Services Market in North America: Distribution by Application Area
13.4.3. DNA Synthesis Services Market in North America: Distribution by Company Size
13.5. DNA Synthesis Services Market in Europe
13.5.1. DNA Synthesis Services Market in Europe: Distribution by Method of DNA Synthesis
13.5.2. DNA Synthesis Services Market in Europe: Distribution by Application Area
13.5.3. DNA Synthesis Services Market in Europe: Distribution by Company Size
13.6. DNA Synthesis Services Market in Asia-Pacific and Rest of the World
13.6.1. DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Method of DNA Synthesis
13.6.2. DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Application Area
13.6.3. DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Company Size
14. CONCLUDING REMARKS15. APPENDIX 1: TABULATED DATA16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
List of Figures
Figure 3.1 DNA Synthesis 5’ to 3’
Figure 3.2 DNA Synthesis: Direction of Fork Movement
Figure 3.3 Leading Strand Synthesis
Figure 3.4 Lagging Strand Synthesis
Figure 3.5 Applications of DNA Synthesis
Figure 4.1 DNA Synthesis Technologies and Services: Distribution by Type of Offering
Figure 4.2 DNA Synthesis Technologies and Services: Distribution by Method of DNA Synthesis
Figure 4.3 DNA Synthesis Technologies and Services: Distribution by Type of DNA Molecule
Figure 4.4 DNA Synthesis Technologies and Services: Distribution by Custom Offerings
Figure 4.5 DNA Synthesis Technologies and Services: Distribution by Application Area
Figure 4.6 DNA Synthesis Technologies and Service Providers: Distribution by Year of Establishment
Figure 4.7 DNA Synthesis Technologies and Service Providers: Distribution by Company Size
Figure 4.8 DNA Synthesis Technologies and Service Providers: Distribution by Location of Headquarters
Figure 4.9 DNA Synthesis Technologies and Service Providers: Distribution by Application Area and Region
Figure 5.1 Ajinomoto Bio-Pharma Services: Annual Revenues Since 2018(JPY Billion)
Figure 5.2 Eurofins Genomics: Annual Revenues FY 2018- FY 2021 (JPY Billion)
Figure 5.3 GenScript: Annual Revenues, Since 2018(USD Billion)
Figure 6.1 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Year of Establishment
Figure 6.2 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Company Size
Figure 6.3 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Scale of Operation
Figure 6.4 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Geographical Location
Figure 6.5 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Location of Manufacturing Facilities (Country-wise)
Figure 6.6 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Regulatory Accreditations / Certifications
Figure 6.7 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Oligonucleotide Manufactured
Figure 6.8 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Offering
Figure 6.9 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Company Size and Type of Offering
Figure 6.10 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Oligonucleotide Manufactured and Type of Offering (Custom Synthesis)
Figure 6.11 Oligonucleotide Manufacturers Focused on Research and Diagnostic Applications: Distribution by Type of Manufacturing Service(s) Offered
Figure 7.1 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Year of Establishment
Figure 7.2 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Company Size
Figure 7.3 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Scale of Operation
Figure 7.5 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Geographical Location
Figure 7.6 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Location of Manufacturing Facilities (Country-wise)
Figure 7.7 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Regulatory Accreditations / Certifications
Figure 7.8 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Oligonucleotide Manufactured
Figure 7.9 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Offering
Figure 7.10 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Company Size and Type of Offering
Figure 7.11 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Oligonucleotide Manufactured and Type of Offering (Modification)
Figure 7.13 Oligonucleotide Manufacturers Focused on Therapeutic Applications: Distribution by Type of Manufacturing Service (s) Offered
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Type of Partner
Figure 8.4 Partnerships and Collaborations: Distribution by Year and Type of Partner
Figure 8.5 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.6 Most Active Players: Distribution by Number of Partnerships
Figure 8.7 Partnerships and Collaborations: Regional Distribution
Figure 8.8 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.1 DNA Synthesis Technologies: Cumulative Distribution by Year of Investment
Figure 9.2 DNA Synthesis Technologies: Cumulative Amount Invested by Year
Figure 9.3 Funding and Investments: Distribution by Type of Funding
Figure 9.4 Funding and Investments: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 9.5 Funding and Investments: Distribution by Type of Venture Capital Funding
Figure 9.6 Most Active Players: Distribution by Number of Funding Instances
Figure 9.7 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 9.8 Funding and Investments: Distribution of Investors by Number of Instances
Figure 9.9 Funding and Investments: Regional Distribution by Amount Invested
Figure 9.10 Summary of Funding and Investments
Figure 10.1. Grant Analysis: Distribution by Year of Grant Award
Figure 10.2. Grant Analysis: Distribution by Grant Amount Awarded (USD Million)
Figure 10.3. Grant Analysis: Distribution by Administering Institute Center
Figure 10.4. Grant Analysis: Distribution by Support Period
Figure 10.5. Grant Analysis: Distribution by Administering Institute Center and Support Period
Figure 10.6. Grant Analysis: Distribution by Type of Grant Application
Figure 10.7. Grant Analysis: Distribution by Grant Activity Code
Figure 10.8. Word Cloud Analysis: Emerging Focus Areas
Figure 10.9. Grant Analysis: Distribution by Purpose of Grant Award
Figure 10.10. Popular NIH Departments: Distribution by Number of Grants
Figure 10.11. Grant Analysis: Distribution by Type of Recipient Organization
Figure 10.12. Prominent Program Officers: Distribution by Number of Grants
Figure 11.1 Publication Analysis: Cumulative Year-wise Trend
Figure 11.2 Publication Analysis: Quarterly Distribution of Publications
Figure 11.3 Publication Analysis: Distribution by Type of Article
Figure 11.4 Word Cloud Analysis: Emerging Focus Areas
Figure 11.5 Analysis by Popular Keywords
Figure 11.6 Most Popular Authors: Distribution by Number of Publications
Figure 11.7 Popular Publishers: Distribution by Number of Publications
Figure 11.8 Popular Journals: Distribution by Number of Publications
Figure 11.9 Publication Analysis: Distribution by Therapeutic Area
Figure 11.10 Publication Analysis: Distribution by Geography
Figure 12.1 Patent Analysis: Distribution by Type of Patent
Figure 12.2 Patent Analysis: Cumulative Distribution by Publication Year
Figure 12.3 Patent Analysis: Year-wise Distribution of Granted Patents
Figure 12.4 Patent Analysis: Year-wise Distribution of Filed Patents
Figure 12.5 Patent Analysis: Distribution by Type of Patent and Publication Year
Figure 12.6 Patent Analysis: Distribution by Issuing Authority
Figure 12.7 Patent Analysis: Distribution by CPC Symbols
Figure 12.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Figure 12.9 Word Cloud Analysis: Emerging Focus Areas
Figure 12.10 Leading Industry Players: Distribution by Number of Patents
Figure 12.11 Leading Non-Industry Players: Distribution by Number of Patents
Figure 12.12 Patent Analysis: Distribution by Patent Age
Figure 12.13 Patent Analysis: Distribution by Relative Valuation
Figure 13.1 Global DNA Synthesis Services Market: Distribution by Method of DNA Synthesis (USD Million)
Figure 13.2 Global DNA Synthesis Services Market: Distribution by Company Size (USD Million)
Figure 13.3 Global DNA Synthesis Services Market: Distribution by Application Area (USD Million)
Figure 13.4 Global DNA Synthesis Services Market: Distribution by Geography (USD Million)
Figure 13.5 DNA Synthesis Services Market in North America (USD Million)
Figure 13.6 DNA Synthesis Services Market in North America: Distribution by Method of DNA Synthesis (USD Million)
Figure 13.7 DNA Synthesis Services Market in North America: Distribution by Application Area (USD Million)
Figure 13.8 DNA Synthesis Services Market in North America: Distribution by Company Size (USD Million)
Figure 13.9 DNA Synthesis Services Market in Europe (USD Million)
Figure 13.10 DNA Synthesis Services Market in Europe: Distribution by Method of DNA Synthesis (USD Million)
Figure 13.11 DNA Synthesis Services Market in Europe: Distribution by Application Area (USD Million)
Figure 13.12 DNA Synthesis Services Market in Europe: Distribution by Company Size (USD Million)
Figure 13.13 DNA Synthesis Services Market in Asia-Pacific and Rest of the World (USD Million)
Figure 13.14 DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Method of DNA Synthesis (USD Million)
Figure 13.15 DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Application Area (USD Million)
Figure 13.16 DNA Synthesis Services Market in Asia-Pacific and Rest of the World: Distribution by Company Size (USD Million)
Figure 14.1 Concluding Remarks: Overall Market Landscape of DNA Synthesis Technologies and Services
Figure 14.2 Concluding Remarks: Partnerships and Collaborations
Figure 14.3 Concluding Remarks: Funding and Investments
Figure 14.4 Concluding Remarks: Grant Analysis
Figure 14.5 Concluding Remarks: Publication Analysis
Figure 14.6 Concluding Remarks: Patent Analysis

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ajinomoto Bio-Pharma Services
  • Aldevron
  • AltaBioscience
  • Ansa Biotechnologies
  • Arbor Biosciences
  • ATUM
  • Beijing SBS
  • Bio Basic
  • Biolegio
  • Biomatik
  • Bioneer
  • Biosearch Technologies
  • Bio-Synthesis
  • Blue Heron Biotech
  • BOC Sciences
  • BR Biochem Life Sciences
  • Camena Bioscience
  • Catalog
  • ChemGenes Corporation
  • Creative Biogene
  • CustomArray
  • CyberGene
  • Dalton Pharma Services
  • DNA Script
  • Eton Bioscience (Subsidiary of Codex DNA)
  • Eurofins Genomics
  • Eurogentec
  • Evonetix
  • Futuresynthesis
  • Gene Universal
  • General Biosystems
  • Generi Biotech
  • Genewiz
  • GenScript
  • Glen Research
  • Helixworks Technologies
  • IBA Lifesciences
  • Integrated DNA Technologies
  • Iridia
  • KareBay Biochem
  • Kern Systems
  • Kilobaser
  • LC Sciences
  • metabion
  • Microsoft
  • Microsynth
  • Midland Certified Reagent Company
  • Molecular Assemblies
  • Moligo Technologies
  • Nitto Denko Avecia
  • Nuclera Nucleics
  • Oligomer Biotechnology
  • Origene
  • ProMab Biotechnologies
  • ProteoGenix
  • Quintaribio
  • Ribbon Biolabs
  • SARTOMED
  • Sigma-Aldrich (Acquired by Merck)
  • Sunomix Biosciences
  • Synbio Technologies
  • Syngene
  • SynHelix
  • Synthomics
  • TAG Copenhagen
  • Thermo Fisher Scientific
  • Xcelris Labs
  • Yale School of Medicine
  • GE Research
  • Baseclick
  • French Ministry for Armed Forces
  • Dynamic Combinatorial Chemistry (DCC)
  • Bright Peak Therapeutics
  • Trio Pharmaceuticals
  • GeneDesign
  • BIOfidal
  • Transcenta
  • Amptec
  • Eton Bioscience
  • Glen Research Corporation
  • CodexisCodexis
  • TeselaGen Biotechnology
  • Analog Devices
  • imec
  • LioniX International
  • PeproTech
  • Patheon
  • GSL Biotech
  • Twist Bioscience
  • Horizon Discovery
  • CustomArray
  • Blue Heron Biotech
  • SynHelix
  • Isolere Bio
  • Aldevron
  • Biotechnolabs
  • iGEM
  • Integrated DNA Technologies
  • GENEWIZ
  • Eurofins Genomics
  • Kazusa DNA Research Institute
  • GeneBay
  • Aldevron
  • Agilent Technologies
  • Illumina Ventures
  • Sofinnova Partners
  • Kurma Partners
  • Casdin Capital
  • Danaher Life Sciences
  • M Ventures
  • Columbia Threadneedle Investments
  • Casdin Capital
  • Alexandria Venture Investments
  • iSelect Fund
  • Codexis
  • Argonautic Ventures
  • Horizons Ventures
  • Mubadala Capital
  • Humboldt Fund
  • National Science Foundation
  • Civilization Ventures
  • Illumina Ventures
  • Merck Ventures
  • Idinvest Partners
  • Bpifrance
  • Bpifrance
  • Life Sciences Partners
  • M. Ventures
  • Kurma Partners and Idinvest Partners
  • Bpifrance
  • Merck
  • Life Sciences Partners
  • Bpifrance
  • Life Science Partners
  • Bpifrance Large Venture Fund
  • Alexandria Venture
  • Fidelity Management and Research
  • Arrowmark Partners
  • Farallon Capital
  • Moore Strategic Ventures
  • National Human Genome Research Institute
  • Coatue Management
  • Catalio Capital Management
  • Fidelity Management & Research Company
  • eureKARE
  • Irving Investors
  • IST Cube
  • tecnet equity
  • Hadean Ventures
  • Lansdowne Partners
  • Helicase Venture
  • IST cube
  • tecnet equity
  • iSelect Fund
  • Keshif Ventures
  • Agilent Technologies
  • LYFE Capital
  • National Human Genome Research Institute
  • SynBio Innovation Accelerator
  • LYFE Capital
  • DCVC
  • Rising Tide
  • Providence Investment Company Limited
  • Molten Ventures
  • Cambridge Consultants
  • Innovate UK
  • Draper Esprit
  • DCVC (Data Collective)
  • The Morningside group
  • Providence Investment Company
  • Cambridge Consultants
  • Rising Tide Fund
  • Tech Coast Angels
  • The Department of Air Force
  • Department of Health and Human Services
  • TEEC Angel Fund
  • TA Associates
  • Colibri Ventures
  • Vanderbilt University
  • Division of Basic Sciences
  • Columbia University Health Sciences
  • Medical College of Wisconsin
  • Eunice Kennedy Shriver National Institute of Child Health & Human Development
  • Univ Of North Carolina Chapel Hill
  • Weill Medical Coll of Cornell Univ
  • University of Minnesota
  • University of Iowa
  • National Institute on Aging
  • National Institute of Environmental Health Sciences
  • University of Wisconsin-Madison
  • Life Technologies
  • Tosoh
  • Achillion Pharmaceuticals
  • Harvard College
  • Broad Institute

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

Organs-on-Chips Market: Industry Trends and Global Forecasts, Till 2035 - Product Image

Organs-on-Chips Market: Industry Trends and Global Forecasts, Till 2035

  • Report
  • 218 Pages
  • Global
From
Metal Roofing Market - Global Forecast 2025-2032 - Product Image

Metal Roofing Market - Global Forecast 2025-2032

  • Report
  • 186 Pages
  • Global
From
Construction Films Market - Global Forecast 2025-2032 - Product Image

Construction Films Market - Global Forecast 2025-2032

  • Report
  • 194 Pages
  • Global
From
Fencing Market - Global Forecast 2025-2032 - Product Image

Fencing Market - Global Forecast 2025-2032

  • Report
  • 188 Pages
  • Global
From
Rain Gutter Market - Global Forecast 2025-2030 - Product Image

Rain Gutter Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.